do not combine dpp-4 inhibitor with glp-1 receptor agonist guideline inhibitors agonists guidance SGLT-2 inhibitors, GLP do not combine dpp-4 inhibitors
Description
Lixisenatide is administered OD 16
[DOI] [PMC free article] [PubMed] [Google Scholar] 78.Lv D., Feng P., Guan X., et al

While IIH can be a deleterious condition leading to visual worsening or even blindness, it is also associated with reduced quality of life due to severe headache [27]

Specifically, Saxenda is indicated for chronic weight management in obese adults (BMI 30) or those merely overweight with a BMI 27 and a weight-related comorbidity such as hypertension, dyslipidemia, or diabetes

These medications, when used correctly with proper medical supervision and lifestyle modifications, can be genuinely life-changing
